None listed
Conditions
Brief summary
Our hypothesis is that patients with moderate to severe arthritis of the hands will find the new writing-aid easier to use and therefore easier to write with. The aim of this study is to trial the writing-aid in clinical practice, with two distinct clear research questions in mind: 1. Is the participants’ handwriting improved with the writing-aid compared to a commercially available aid? 2. Do the participants find the writing-aid comfortable and easy to use?
Interventions
Participants will be issued with a mouldable pen (designed at Unitec) to use for 8 weeks.
The researcher will show the participant how to mould the pen initially. It can then "set" into shape or be re-moulded if the participant wishes.
The pen has a latex exterior, the design of the internal contents are the intellectual property of the designer and Unitec Institute of Technology.
Participants are asked to use the pen as they would a normal pen and to note when they use it.
Sponsors
Unitec Institute of Technology
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
65 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
Osteoarthritis in writing hand. Reside in Auckland, NZ.
Exclusion criteria
Cognitive impairments that may affect their ability to perform a handwriting assessment. Hand surgery within the last six months. Current treatment with cortisone. Latex allergy.
Outcome results
None listed